In 182 women with early-onset severe preeclampsia, recombinant antithrombin-gamma did not significantly prolong pregnancy vs placebo (16.9 vs 13 days; P=0.07), and haemorrhage-related adverse events (+19.0%) and anaemia (+16.8%) were more common.
RCTn = 182
Takeda et al. Randomized Study of Antithrombin in Early-Onset Preeclampsia: KOUNO-TORI Study